Exosome-mediated delivery of siRNA in vitro and in vivo

Nature Protocols

Volumn 7, Issue 12, 2012, Pages 2112-2126

  El Andaloussi, Samir ^a,b   Lee, Yi ^a   Lakhal Littleton, Samira ^a   Li, Jinghuan ^a   Seow, Yiqi ^c   Gardiner, Chris ^d   Alvarez Erviti, Lydia ^e   Sargent, Ian L ^d   Wood, Matthew J A ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c AGENCY FOR SCIENCE   (Singapore)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

SMALL INTERFERING RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DENDRITIC CELL; EXOSOME; EXPERIMENTAL DESIGN; EXPRESSION VECTOR; GENE DELIVERY SYSTEM; GENE SEQUENCE; GENE SILENCING; GENETIC TRANSFECTION; IN VITRO STUDY; IN VIVO STUDY; INTERMETHOD COMPARISON; LIGAND BINDING; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROTEIN PURIFICATION; RNA INTERFERENCE;

EID: 84870575710     PISSN: 17542189     EISSN: 17502799     Source Type: Journal    
DOI: 10.1038/nprot.2012.131     Document Type: Article

References (23)

1. Simpson, R.J., Lim, J.W., Moritz, R.L. & Mathivanan, S. Exosomes: Proteomic insights and diagnostic potential. Expert Rev. Proteomics 6, 267-283 (2009
2. Morelli, A.E. et al. Endocytosis, intracellular sorting, and processing of exosomes by dendritic cells. Blood 104, 3257-3266 (2004 (Pubitemid 39507144)
3. Baj-Krzyworzeka, M. et al. Tumour-derived microvesicles carry several surface determinants and mRNA of tumour cells and transfer some of these determinants to monocytes. Cancer Immunol. Immunother. 55, 808-818 (2006
4. Ratajczak, J. et al. Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: Evidence for horizontal transfer of mRNA and protein delivery. Leukemia 20, 847-856 (2006
5. Valadi, H. et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat. Cell Biol. 9, 654-659 (2007 (Pubitemid 47214727)
6. Mittelbrunn, M. et al. Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells. Nat. Commun. 2, 282 (2011
7. Montecalvo, A. et al. Mechanism of transfer of functional microRNAs between mouse dendritic cells via exosomes. Blood 119, 756-766 (2012
8. Gibbings, D.J., Ciaudo, C., Erhardt, M. & Voinnet, O. Multivesicular bodies associate with components of miRNA effector complexes and modulate miRNA activity. Nat. Cell Biol. 11, 1143-1149 (2009
9. Alvarez-Erviti, L. et al. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat. Biotechnol. 29, 341-345 (2011
10. Quah, B.J.C. & O'Neill, H.C. The immunogenicity of dendritic cell-derived exosomes. Blood Cells Mol. Dis. 35, 94-110 (2005 (Pubitemid 41267035)
11. Bettens, K. et al. APP and BACE1 miRNA genetic variability has no major role in risk for Alzheimer disease. Hum. Mutat. 30, 1207-1213 (2009
12. Godlewski, J. et al. Targeting of the Bmi-1 oncogene/stem cell renewal factor by microRNA-128 inhibits glioma proliferation and self-renewal. Cancer Res. 68, 9125-9130 (2008
13. Kefas, B. et al. microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma. Cancer Res. 68, 3566-3572 (2008
14. Subra, C., Laulagnier, K., Perret, B. & Record, M. Exosome lipidomics unravels lipid sorting at the level of multivesicular bodies. Biochimie 89, 205-212 (2007 (Pubitemid 46161956)
15. Zhuang, X. et al. Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain. Mol. Ther. 19, 1769-1779 (2011
16. Lentz, T.L. Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J. Mol. Recognit. 3, 82-88 (1990
17. El-Andaloussi, S., Holm, T. & Langel, U. Cell-penetrating peptides: Mechanisms and applications. Curr. Pharm. Des. 11, 3597-3611 (2005 (Pubitemid 41630987)
18. Ezzat, K., El Andaloussi, S., Abdo, R. & Langel, U. Peptide-based matrices as drug delivery vehicles. Curr. Pharm. Des. 16, 1167-1178 (2010
19. Muntoni, F. & Wood, M.J.A. Targeting RNA to treat neuromuscular disease. Nat. Rev. Drug Discov. 10, 621-637 (2011
20. Andaloussi, S.E.L. et al. Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivo. Nucleic Acids Res. 39, 3972-3987 (2011
21. Vivès, E., Brodin, P. & Lebleu, B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J. Biol. Chem. 272, 16010-16017 (1997 (Pubitemid 27265584)
22. Walton, S.P., Wu, M., Gredell, J.A. & Chan, C. Designing highly active siRNAs for therapeutic applications. FEBS. J. 277, 4806-4813 (2010
23. Dragovic, R.A. et al. Sizing and phenotyping of cellular vesicles using Nanoparticle Tracking Analysis. Nanomedicine 7, 780-788 (2011).